Merck Profile

<div class='circular--portrait' style='background:#FF6600;color: white;font-size:3em;padding-top: 35px;;'>MRK</div>

Performance

5 / 100

Odds of Distress

13
Equity ratings for Merck Company are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting October 29, 2019 and ending today January 27, 2020. Click here to learn more.

Merck Profile

Upcoming quarterly earning report is expected on February 5, 2020. The stock continues to go through above average trading activities. The company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases neuromuscular blocking agents cholesterol modifying medicines and anti-bacterial and vaginal contraceptive products. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey. Merck operates under Drug ManufacturersGeneral classification in USA and is traded on BATS Exchange. It employs 69000 people. more on Merck
Merck Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Merck SEC Filings
Merck SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NameMerck Company
Older SymbolSGP
ChairmanKenneth FrazierView All
Thematic Classifications
Active investing themes Merck currently participates. An investing theme is an unweighted collection of funds, stocks, ETFs or cryptocurrencies
showing 2 out of 4 themes  View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Merck
Piotroski F Score
Academic score to determine the current strength of Merck financial position
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Financial Strength
Merck ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Long Term Debt to Equity
Debt to Equity Ratio
Return on Investment
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Average Bond Rating: AA-Very Strong
Profitability
Few selected profitability drivers of Merck representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
Net Income Per Employee
Operating Margin
EBITDA Margin
Gross Margin
Profit Margin
Merck Company (MRK) is traded on BATS Exchange in USA. It is located in 2000 Galloping Hill Road, Kenilworth, NJ 07033, United States and employs 69,000 people. Merck Company was previously known as Merck Co and was traded on BATS Exchange under the symbol SGP. Merck is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with total capitalization of 214.76 B. Merck runs under Healthcare sector within Drug Manufacturers?General industry. The entity has 2.56 B outstanding shares of which 25.15 M shares are now shorted by investors with about 3.42 days to cover shorted positions. MERCK CO INC has about 7.1 B in cash with 9.63 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.78.
Check Merck Probability Of Bankruptcy

Ownership Allocation (%)

Merck Target Price Odds Analysis

Odds Below 85.98HorizonTargetOdds Above 85.98
30.17%30 days 85.98 69.55%
Based on normal probability distribution, the odds of Merck to move above current price in 30 days from now is about 69.55 (This Merck Company probability density function shows the probability of Merck Stock to fall within a particular range of prices over 30 days) .

Merck Top Holders

Merck Company Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

Merck Against Markets

Did you try this?

Run Global Markets Map Now

   

Global Markets Map

Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
All  Next Launch Module

Merck Upcoming and Recent Events

Merck Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportFebruary 5, 2020
Next Earnings ReportMay 5, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndFebruary 5, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

Merck Corporate Filings

Merck SEC Reporting

Unclassified Corporate Event
Financial Statements and Exhibits. Results of Operations and Financial Condition
Submission of Matters to a Vote of Security Holders

Merck Distributions to stockholders

Merck Corporate Directors

Thomas Glocer Independent Director
Craig Thompson Independent Director
Rochelle Lazarus Independent Director
Additionally see Stocks Correlation. Please also try Money Flow Index module to determine momentum by analyzing money flow index and other technical indicators.
Company logos by clearbit